Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs in Healthy Korean Adults After a Single Oral Administration of Escitalopram, Quetiapine, and Moxifloxacin

Trial Profile

Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs in Healthy Korean Adults After a Single Oral Administration of Escitalopram, Quetiapine, and Moxifloxacin

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Escitalopram (Primary) ; Quetiapine (Primary)
  • Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Alcoholism; Bipolar depression; Borderline personality disorders; Community-acquired pneumonia; Delirium; Intra-abdominal infections; Major depressive disorder; Manic episodes; Schizophrenia; Skin and soft tissue infections; Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Mar 2016 Results published in the International Clinical Psychopharmacology
    • 25 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top